The Chemours Company (CC) – The Long Game That Investors Are Missing

VERGNANO MARK P, President and CEO, added 44,000 shares of The Chemours Company (CC) to its portfolio at the rate of $23.17 per share valuing $1,019,467 on Jun 10. The insider has now 116,600 shares of the company to its portfolio. Before making a move on any particular stock, readers often pay close attention to support and resistance markers. The last reported price for shares of The Chemours Company (CC) was $19.16. Currently, the 1st Resistance Point for this stock is $19.64, with a 2nd Resistance Point sitting at $20.12. Meanwhile, this company’s stock has a 1st Support Level at $18.71 and a 2nd Support Level at $18.26. The Chemours Company (CC) stock has lost -$2.37, or -11.01%, in the past five days. In the last full month, these shares have lost -$4.69, or -19.66%. In the past three months, this stock’s price has fallen by -$19.70, or -50.69%. This year-to-date, The Chemours Company (CC) shares have lost -$9.06, or -32.10%.

Analyzing price projection indicators is a helpful way to determine whether a potential stock buy is a wise choice for profits in the short term, medium term, and long term. For The Chemours Company (CC) stock, 80% of short-term indicators suggest that these shares are a “ Sell .” Meanwhile, 100% of medium-term indicators point to this stock being a “ Sell .” Looking further ahead, 67% of long-term indicators suggest that this stock is a “ Sell .”

With 163,964 K shares outstanding, this company currently has a market capitalization of $3,220,253K. The Chemours Company (CC) generates $6,638 M in annual sales, amounting to annual net income of $995,000 K. This stock has generated a 1-Year Total Return of -56.47%, a 3-Year Total Return of 115.04%, and a 5-year Total Return of 0.00%. This stock’s 5-Year Dividend Growth is 0.00%, with its most recent dividend valued at $0.250 per share on 05/15/19. Its Annual Dividend Yield is 5.09%, and its Annual Dividend Rate is 1.00.

In the most recently-reported fiscal quarter, which ended in Mar-19, The Chemours Company (CC) reported earnings of $0.63 per share. Wall Street analysts, on average, were expecting the company to report earnings of $0.90 per share, representing a -0.27 difference and 29.84% surprise. In the previous quarter ending in Dec-18, the reported earnings of $1.05 represented a 0.06 difference from the consensus estimate calling for $0.99 per share, which was a 5.64% surprise.

For the current fiscal quarter, which is set to end in 06/2019, the average earnings estimate is $0.89 per share. This estimate came from a total of 4 Wall Street Analysts. Of those market experts, the high estimate was $1.04 and the low estimate was $0.78. In the year-ago quarter, The Chemours Company (CC) generated per-share earnings of $1.71. If the analysts are correct about the current quarter’s earnings, the growth will be -47.95% .

Turning our focus now to insider trading activity, there have been 12 purchases (129,699 shares in total) and 0 sale (0 shares in total) in the last 3 months. In the last 6 months, there have been 23 insider buys amounting to 1,478,419 shares and 13 insider sales amounting to 560,441 shares. In the past full year, 24 insider purchases were made (involving 1,488,419 shares) and 19 insider sell-offs equivalent to 690,023 shares.

Moving onto liquidity, The Chemours Company (CC) has a Current Ratio of 1.93, a Quick Ratio of 1.26 and a Cash Ratio of 0.70. Looking at this company’s capital structure, its Total Debt to Total Equity is 391.72, its Total Debt to Total Capital is 79.66, and its Total Debt to Total Assets is now 53.95. Looking even further ahead into the future, its Long-Term Debt to Equity is 390.43 and its Long-Term Debt to Total Capital is 79.40.